ZURICH (Thomson Financial) - Lonza Group AG said it now manufactures and sells Poietics Human Adipose-Derived Stem Cells (ADSC) for use in adult stem cell research.
The ADSC system provides research laboratories with ready to use cells and media for research in areas such as tissue repair, wound healing, cell differentiation, osteoporosis, insulin resistance or obesity, the Swiss life science group said.
Lonza manufactures and sells these cells through a commercial license with Cytori Therapeutics, the leader in adipose-derived cell therapy.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment